SCHEMBL1094480

SCHEMBL1094480

CC1(C)CCCC2(C)C1CCC1(C)OC(=O)CC12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 1.00
▸ CYP3A4 P08684 1/20 1.00
▸ CYP2C9 P11712 1/20 1.00
▸ TSHR P16473 1/20 1.00
▸ CYP2C19 P33261 1/20 1.00
▸ ENTPD5 O75356 1/20 0.54
▸ RPS6KA5 O75582 3/20 0.46
▸ MAPKAPK2 P49137 3/20 0.46
▸ LTB4R Q15722 1/20 0.46
▸ ALOX15 P16050 2/20 0.44
▸ ALOX12 P18054 2/20 0.44
▸ NR1H4 Q96RI1 3/20 0.40
▸ PTPN1 P18031 4/20 0.40
▸ HIF1A Q16665 3/20 0.40
▸ EPAS1 Q99814 3/20 0.40
▸ IDO1 P14902 1/20 0.39
▸ PIK3CB P42338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6251885 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL9289576 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL13206588 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL9400263 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL13223919 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL17030368 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL12794189 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL14029401 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL9880769 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL18256420 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 — — EP claimed
CN-109912550-B Pasteur martin and preparation method thereof 云南农业大学 2022-02-11 — — CN claimed
US-10548935-B2 Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting MARS, INCORPORATED (US) 2020-02-04 — — US claimed
EP-2986136-A1 COMPOSITION AND METHOD FOR PREVENTING, REDUCING, ALLEVIATING, OR TREATING IDIOPATHIC VOMITING The Iams Company (US) 2016-02-24 — — EP claimed
CN-105188400-A Compositions and methods for preventing, reducing, alleviating, or treating idiopathic vomiting IAMS COMPANY 2015-12-23 — — CN claimed
EP-1997879-B1 MICROORGANISM AND METHOD FOR PRODUCING DECAHYDRO-2-HYDROXY-2,5,5,8a-TETRAMETHYLNAPHTHALENEETHANOL AND/OR SCLAREOLIDE (DECAHYDRO-3a,6,6,9a- TETRAMETHYLNAPHTHO[2,1-b]FURAN-2(1H)-ONE) USING THE SAME KAO CORP (JP) 2015-07-01 — — EP claimed
WO-2014143539-A1 COMPOSITION AND METHOD FOR PREVENTING, REDUCING, ALLEVIATING, OR TREATING IDIOPATHIC VOMITING THE IAMS COMPANY (US) 2014-09-18 — — WO claimed
US-20140271949-A1 Composition and Method for Preventing, Reducing, Alleviating or Treating Idiopathic Vomiting THE IAMS COMPANY (US) 2014-09-18 — — US claimed
EP-2123765-B1 Method for production of microbial fermentation product KAO CORP (JP) 2013-07-31 — — EP claimed
EP-2396310-B1 PROCESS FOR PRODUCING (±)-3a,6,6,9a-TETRAMETHYL DODECAHYDRONAPHTHO[2,1-b]FURANS KAO CORP (JP) 2013-04-03 — — EP claimed
US-8084237-B2 Microorganism and method for producing dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan intermediate using the novel microorganism KAO CORPORATION (JP) 2011-12-27 — — US claimed
US-20100233766-A1 Novel Microorganism and Method for Producing Dodecahydro-3a,6,6,9a-Tetramethylnaphtho[2,1-b]Furan Intermediate Using the Novel Microorganism KAO CORPORATION (JP) 2010-09-16 — — US claimed
US-20100028964-A1 METHOD FOR PRODUCTION OF MICROBIAL FERMENTATION PRODUCT KAO CORPORATION (JP) 2010-02-04 — — US claimed
EP-2123765-A1 METHOD FOR PRODUCTION OF MICROBIAL FERMENTATION PRODUCT Kao Corporation (JP) 2009-11-25 — — EP claimed
US-20090270639-A1 PROCESS FOR PRODUCTION OF (±)-3A,6,6,9A- TETRAMETHYLDECAHYDRONAPHTHO[2,1-B]FURAN-2(1H)-ONE KAO CORPORATION (JP) 2009-10-29 — — US claimed
EP-2048139-A1 PROCESS FOR PRODUCTION OF (±)-3a,6,6,9a TETRAMETHYLDECAHYDRONAPHTHO[2,1-b]FURAN-2(1H)-ONE Kao Corporation (JP) 2009-04-15 — — EP claimed
EP-1997879-A1 NOVEL MICROORGANISM AND METHOD FOR PRODUCING DODECAHYDRO-3A,6,6,9A-TETRAMETHYLNAPHTHO[2,1-B]-FURAN INTERMEDIATE USING THE SAME Kao Corporation (JP) 2008-12-03 — — EP claimed
EP-0550889-B1 Process for producing L-Ambrox KURARAY CO (JP) 1996-09-18 — — EP claimed
US-5290955-A Process for producing L-ambrox KURARAY CO., LTD. (JP) 1994-03-01 — — US claimed
EP-0550889-A1 Process for producing L-Ambrox KURARAY CO., LTD. (JP) 1993-07-14 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270639-A1 PROCESS FOR PRODUCTION OF (±)-3A,6,6,9A- TETRAMETHYLDECAHYDRONAPHTHO[2,1-B]FURAN-2(1H)-ONE COASY, FASN, CYP2C9 ALDH1A1 219/4885CYP3A4 38/4885CYP2C9 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback